NCT03524989 (SPORTRCT) is a NA clinical trial of Hyperbaric Oxygen Therapy in Healthy, sponsored by Assaf-Harofeh Medical Center.

Who is sponsoring NCT03524989?

NCT03524989 is sponsored by Assaf-Harofeh Medical Center.

What drugs are being tested in NCT03524989?

Interventions in NCT03524989: Hyperbaric Oxygen Therapy, SHAM treatment.

What condition does NCT03524989 study?

NCT03524989 studies Healthy, Athletes.

Is NCT03524989 still recruiting?

NCT03524989 is currently completed. Last updated 6 December 2022.

Last reviewed 2022-12-06 · How we verify

NCT03524989: SPORTRCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Hyperbaric Oxygen Therapy on Aerobic and Anaerobic Physical Fitness

Completed NA Last updated 6 December 2022

What this trial tests

NA trial testing Hyperbaric Oxygen Therapy in Healthy in 59 participants. Completed in 15 September 2021.

Timeline

15 May 2018

Primary endpoint
15 September 2021

15 September 2021

Quick facts

Lead sponsor	Assaf-Harofeh Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	treatment
Enrollment	59
Start date	15 May 2018
Primary completion	15 September 2021
Estimated completion	15 September 2021
Sites	1 location across Israel

Drugs / interventions tested

Hyperbaric Oxygen Therapy — full drug profile →
SHAM treatment — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →
Athletes — all drugs for Athletes →

Sponsor

Assaf-Harofeh Medical Center

Who can join

Adults 18 to 50, any sex, with Healthy or Athletes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Previous evidence showed hyperbaric oxygen can enhance aerobic and anaerobic performance during the exposure. The effect of continuous exposure of hyperbaric oxygen on performance was never evaluated.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of Hyperbaric Oxygen Therapy on Mitochondrial Respiration and Physical Performance in Middle-Aged Athletes: A Blinded, Randomized Controlled Trial.
Hadanny A, Hachmo Y, Rozali D, Catalogna M, et al · · 2022 · cited 19× · PMID 35133516 · DOI 10.1186/s40798-021-00403-w

Verify or expand the search:

Other trials of Hyperbaric Oxygen Therapy

Trials testing the same drug.

NCT07473362 — Hyperbaric Oxygen Therapy for Post Traumatic Stress Disorder - a Pragmatic, Double Blinded Randomized Trial · NA · recruiting
NCT07049692 — Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy · NA · not yet recruiting
NCT07514728 — Concept-verification Clinical Trial on the Inhibition of Breast Cancer Lung Metastasis Progression by Hyperbaric Oxygen · NA · enrolling by invitation
NCT07170020 — Hyperbaric Oxygen Treatment for Necrotizing Fasciitis and Necrotizing Soft Tissue Infections · NA · not yet recruiting
NCT07214415 — Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy · Phase 2 · recruiting

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Assaf-Harofeh Medical Center trials

Trials by the same sponsor.

NCT07334639 — Metabolic Changes Associated With Weight Gain After Treatment of Achalasia · not yet recruiting
NCT07276334 — Same Day Discharge Vs. Hospitalization for Operative Fixation of Distal Radius Fractures · NA · enrolling by invitation
NCT07231900 — Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients · Phase 2, PHASE3 · not yet recruiting
NCT07252180 — Comparing Two Different Methods of Ablation of Inlet Patches (APC vs RFA) · NA · active not recruiting
NCT04664790 — Hyperbaric Oxygen Therapy Compared to Cognitive Training in FASD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03524989 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assaf-Harofeh Medical Center
Last refreshed: 6 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03524989.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing